Systematic Examination of Health Inequalities: Documentation, Patterns, and Determinants (CHANCE)
Assessment of Lifestyle Parameters and Biomarkers of Biochemistry and Physiology to Address Health Inequalities: An Exploratory Cohort Study
Studieoversigt
Status
Status
Betingelser
Betingelser
Detaljeret beskrivelse
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Kontakter og lokationer
Studiekontakt
Studiekontakt
- Navn: Aristidis S Veskoukis, Associate Professor
- Telefonnummer: 0030 2431047114
- E-mail: veskoukis@uth.gr
Studiesteder
-
-
-
Larissa, Grækenland
- Ikke rekrutterer endnu
- General Hospital of Larissa
-
Kontakt:
- Grigoris Vlachakis
- Telefonnummer: 0030 2413504100
- E-mail: gen.nosokomeio.laris@ghl.gr
-
Larissa, Grækenland
- Rekruttering
- Health structures in the Region of Thessaly
-
Kontakt:
- Maria Papagianni
- Telefonnummer: 0030 2431047115
- E-mail: mpapag@uth.gr
-
Larissa, Grækenland
- Ikke rekrutterer endnu
- National Organization for the Prevention and Treatment of Addictions (EOPAE)
-
Kontakt:
- Vasilis Pinakas
- Telefonnummer: 0030 2410671842
- E-mail: vpinakas@gmail.com
-
Trikala, Grækenland
- Ikke rekrutterer endnu
- General Hospital of Trikala
-
Kontakt:
- Lia Roganaki, Hospital Administrator
- E-mail: gnt.dioikitis@trikalahospital.gr
-
Trikala, Grækenland
- Ikke rekrutterer endnu
- National Organization for the Prevention and Treatment of Addictions (EOPAE), Trikala
-
Kontakt:
- Marina Papageorgiou
- Telefonnummer: 0030 2431026481
- E-mail: papageorgiou.marina5@gmail.com
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
- Voksen
- Ældre voksen
Tager imod sunde frivillige
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- Adults (>18 years of age)
- All healthy individuals who reside in rural and urban areas
- All patients with non-communicable diseases who reside in rural and urban areas
- Patients with opioid use disorders under medication for addiction treatment with methadone and buprenorphine
- Individuals incarcerated in correctional facilities
Exclusion Criteria:
- Minors (<18 years of age)
- Individuals with communicable diseases
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
Antal grupper/kohorter
Kohorter og interventioner
Gruppe / kohorteGruppe / kohorte |
|---|
|
Patients with non-communicable diseases - residents of rural areas
No intervention
|
|
Patients with non-communicable diseases - residents of urban areas
No intervention
|
|
Healthy volunteers - residents of rural areas
No intervention
|
|
Healthy volunteers - residents of urban areas
No intervention
|
|
Patients with opioid use disorders under medication for addiction treatment
No intervention
|
|
Individuals incarcerated in correctional facilities (prisons)
No intervention
|
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Demographic data
Tidsramme: Data will be collected at Baseline
|
Body mass index, smoking, alcohol consumption, place of residence, health insurance, educational status, family status and financial status will be collected among others through a questionnaire.
|
Data will be collected at Baseline
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Physical activity
Tidsramme: Data will be collected at Baseline
|
It will be measured through the international physical activity questionnaire (IPAC)
|
Data will be collected at Baseline
|
|
Quality of life
Tidsramme: Data will be collected at Baseline
|
It will be measured through the SF-36 questionnaire.
This instrument has a physical component and a mental component.
Each domain is scored from 0 to 100.
Higher score = better health or better quality of life.
|
Data will be collected at Baseline
|
|
Heroin craving
Tidsramme: Data will be collected at Baseline
|
It will be measured using the heroin craving questionnaire (HCQ).
The score is calculated with a 7-point Likert scale ranging from 1 (i.e., strongly disagree) to 7 (i.e., strongly agree).
Higher values = higher craving for heroin use.
It applies only to the patients with opioid use disorders.
|
Data will be collected at Baseline
|
|
Concentration of reduced glutathione (GSH)
Tidsramme: Data will be collected at Baseline
|
The concentration of GSH, a crucial antioxidant metabolite, will be measured in the blood of sub-population of the volunteers
|
Data will be collected at Baseline
|
|
Concentration of protein carbonyls
Tidsramme: Data will be collected at Baseline
|
Concentration of protein carbonyls, a biomarker of protein oxidation, will be measured in the blood of sub-population of the volunteers
|
Data will be collected at Baseline
|
|
Total antioxidant capacity (TAC)
Tidsramme: Data will be collected at Baseline
|
TAC is crude biomarker of antioxidant status and will be measured in the blood of sub-population of the volunteers
|
Data will be collected at Baseline
|
|
Activity of catalase
Tidsramme: Data will be collected at Baseline
|
Activity of catalase, a substantial antioxidant enzyme, will be measured in blood of sub-population of the volunteers
|
Data will be collected at Baseline
|
|
Cardiorespiratory fitness
Tidsramme: Data will be collected at Baseline
|
A marker, which is associated to physical activity and health status, will be measured in sub-population of the volunteers.
In particular, resting energy expenditure and resting heart rate will be assessed through metabolic gas analyzer.
|
Data will be collected at Baseline
|
|
Body fat percentage
Tidsramme: Data will be collected at Baseline
|
It is associated to physical activity and health status and will be measured in sub-population of the volunteers through bioelectrical impedance analysis.
|
Data will be collected at Baseline
|
|
Lean body mass
Tidsramme: Data will be collected at Baseline
|
It is associated to physical activity and health status and will be measured (in kg) in sub-population of the volunteers through bioelectrical impedance analysis.
|
Data will be collected at Baseline
|
|
Muscle mass
Tidsramme: Data will be collected at Baseline
|
It is associated to physical activity and health status and will be measured (in kg) in sub-population of the volunteers through bioelectrical impedance analysis.
|
Data will be collected at Baseline
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Publikationer og nyttige links
Generelle publikationer
- Veskoukis AS, Tsatsakis A, Kouretas D. Approaching reactive species in the frame of their clinical significance: a toxicological appraisal. Food and Chemical Toxicology, 138:111206, 2020.
- Veskoukis AS, Kerasioti E, Priftis A, Kouka P, Spanidis Y, Makri S, Kouretas D. A battery of translational biomarkers for the assessment of the in vitro and in vivo antioxidant action of plant polyphenolic compounds: the biomarker issue. Current Opinion in Toxicology, 13:99-109, 2019.
- Veskoukis AS, Margaritelis NV, Kyparos A, Paschalis V, Nikolaidis MG. Spectrophotometric assays for measuring redox biomarkers in blood and tissues: the NADPH network. Redox Report, 23(1):47-56, 2018.
- Veskoukis AS, Kyparos A, Paschalis V, Nikolaidis MG. Spectrophotometric assays for measuring redox biomarkers in blood. Biomarkers, 21(3):208-17, 2016.
- Dinas PC, On Behalf Of The Students Of Module Introduction To Systematic Reviews, Karaventza M, Liakou C, Georgakouli K, Bogdanos D, Metsios GS. Combined Effects of Physical Activity and Diet on Cancer Patients: A Systematic Review and Meta-Analysis. Nutrients. 2024 Jun 2;16(11):1749. doi: 10.3390/nu16111749.
- Metsios GS, Moe RH, van der Esch M, van Zanten JJCSV, Fenton SAM, Koutedakis Y, Vitalis P, Kennedy N, Brodin N, Bostrom C, Swinnen TW, Tzika K, Niedermann K, Nikiphorou E, Fragoulis GE, Vlieland TPVM, Van den Ende CHM, Kitas GD; IMPACT-RMD Consortium. The effects of exercise on cardiovascular disease risk factors and cardiovascular physiology in rheumatoid arthritis. Rheumatol Int. 2020 Mar;40(3):347-357. doi: 10.1007/s00296-019-04483-6.
- Metsios GS, Moe RH, Kitas GD. Exercise and inflammation. Best Pract Res Clin Rheumatol. 2020 Apr;34(2):101504. doi: 10.1016/j.berh.2020.101504.
- Poulter M, Coe S, Graham CA, Leach B, Tammam J. A systematic review of the effect of dietary and nutritional interventions on the behaviours and mental health of prisoners. Br J Nutr. 2024 Jul 14;132(1):77-90. doi: 10.1017/S0007114524000849.
- da Costa, F.A.; Verschuuren, M.; Andersen, Y.; Stürup-Toft, S.; Lopez-Acuña, D.; Ferreira-Borges, C. The WHO Prison Health Framework: A framework for assessment of prison health system performance. Eur. J. Public Health 2022, 32, 565-570.
- Schoenthaler, S., Gast, D., Giltay, E. J., & Amos, S. (2023). The Effects of Vitamin-Mineral Supplements on Serious Rule Violations in Correctional Facilities for Young Adult Male Inmates: A Randomized Controlled Trial. Crime & Delinquency, 69(4), 822-840.
- Leventelis C, Barmpas PT, Nellas I, Tasoulis S, Veskoukis AS, Tsironi M. COVID-19 Pandemic Detrimentally Affects Craving and Quality of Life in Patients Under Medication-Assisted Treatment with Buprenorphine and Methadone: The Issue of Medication Dose. Psychiatry International, 5, 867-882, 2024.
- Leventelis C, Makri S, Ververi A, Papageorgiou K, Tentolouri A, Mountzouridi E, Tekos F, Barmpas PT, Tasoulis S, Metsios GS, Kouretas D, Veskoukis AS. Pomegranate juice ameliorates craving and oxidative stress on patients under medication for opioid addiction treatment with methadone and buprenorphine: a Ranzomised Controlled Trial. Clinical Nutrition ESPEN, 66, 34-44, 2025a.
- Leventelis C, Veskoukis AS, Rojas Gil AP, Papadopoulos P, Garderi M, Angeli A, Kampitsi A, Tsironi M. Methadone and Buprenorphine as Medication for Addiction Treatment Diversely Affect Inflammation and Craving Depending on Their Doses. Pharmacy (Basel), 13(2), 40, 2025b.
- Leventelis C, Barmpas PT, Kampitsi A, Iliopoulou K, Toutouktsi N, Malakopoulos P, Tasoulis S, Veskoukis AS. Pomegranate juice consumption improves sleep quality and melatonin concentration of patients with opioid use disorders under medication-assisted treatment with methadone and buprenorphine: a randomized controlled trial. Substance Use and Addiction Journal, 46(4):981-993, 2025c.
- Edwards, A., Hung, R., Levin, J. B., Forthun, L., Sajatovic, M., & McVoy, M. (2023). Health disparities among rural individuals with mental health conditions: A systematic literature review. Rural Mental Health, 47(3), 163-178. https://doi.org/10.1037/rmh0000228
- Cosgrave, C., Malatzky, C., & Gillespie, J. (2019). Social determinants of health and the rural health care gap: A scoping review. International Journal of Environmental Research and Public Health, 18(8), 2668. https://doi.org/10.3390/ijerph16030314
- Probst, J. C., Eberth, J. M., & Crouch, E. (2019). Structural urbanism contributes to poorer health outcomes for rural America. Health Affairs, 39(12), 2017-2024. https://doi.org/10.1377/hlthaff.2019.00914
- Holt-Lunstad, J. (2018). Why social relationships are important for physical health: A systems approach to understanding and modifying risk and protection. Annual Review of Psychology, 69, 437-458. https://doi.org/10.1146/annurev-psych-122216-011902
- Umberson, D., & Donnelly, R. (2023). Social isolation: An unequally distributed health hazard. Annual Review of Sociology, 49(1), 379-399. https://doi.org/10.1146/annurev-soc-031021-012001
- Aldridge, R. W., Story, A., Hwang, S. W., Nordentoft, M., Luchenski, S. A., Hartwell, G., & Hayward, A. C. (2018). Morbidity and mortality in homeless individuals, prisoners, sex workers, and individuals with substance use disorders in high-income countries: A systematic review and meta-analysis. https://doi.org/10.1016/S0140-6736(17)31869-X
- Tsai, J., O'Toole, T., & Kearney, L. K. (2017). Homelessness as a public mental health and social problem: New knowledge and solutions. Psychological Services, 14(2), 113-117. https://doi.org/10.1037/ser0000164
- Luchenski, S., Maguire, N., Aldridge, R. W., et al. (2018). What works in inclusion health: Effective interventions for marginalised and excluded populations. The Lancet, 391(10117), 266-280. https://doi.org/10.1016/S0140-6736(17)31959-1
- Triantafyllou, C., Latsou, D., Psiakis, V., Pierrakos, G., & Breda, J. (2025). Addressing health inequalities in Greece: A comprehensive framework for socioeconomic determinants of health. Healthcare, 13(19), 2394. https://doi.org/10.3390/healthcare13192394
- Krieger N. A glossary for social epidemiology: part II. J Epidemiol Community Health. 2001;55(55):693-700. doi: 10.1136/jech.55.10.693.
- OECD. (2025a). Health at a Glance 2025: OECD indicators. OECD Publishing. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en.html
- OECD. (2023). Health at a Glance: Europe 2023. https://www.oecd.org/en/publications/health-at-a-glance-2023_7a7afb35-en.html
- Douki, S., & Spyridakis, E. (2004). Inequalities in access to health services: The case of Greece. HAPSc Policy Briefs Series, 5(2), 27. https://doi.org/10.12681/hapscpbs.40777
- World Health Organization. (2025a). World report on social determinants of health equity 2025. WHO. https://www.who.int/teams/social-determinants-of-health/equity-and-health/world-report-on-social-determinants-of-health-equity
- World Health Organization. (2021). Social determinants of health and health inequalities in Europe. WHO Regional Office for Europe. https://www.who.int/europe/health-topics/social-determinants-of-health
- McCartney, G., Popham, F., McMaster, R., & Cumbers, A. (2019). Defining health and health inequalities. Public Health, 172, 22-30. https://doi.org/10.1016/j.puhe.2019.03.023
- Sartorius, N. (2006). The meanings of health and its promotion. Croatian Medical Journal, 47(4), 662-664. https://pmc.ncbi.nlm.nih.gov/articles/PMC2080455/
- World Health Organization. (2014). Basic documents (48th ed.). WHO.
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- 98 / 25.07.2025
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .